|
ior®EPOCIM in post-COVID-19 convalescent patients with cardiovascular, renal and/or respiratory disorders |
18/06/2021 |
CIM |
|
iorEPOCIM-Stroke-Phase I |
2012-09-17 |
CIMAB |
|
Intravenous CIGB-128-A in patients with brain tumors (BRATINC Study) |
2013-01-17 |
CIGB |
|
Interferon Combination in basal cell carcinoma (InCarbacel-V study) |
2013-02-01 |
CIGB |
|
INJURE Study |
2011-07-11 |
CIGB |
|
Homeostec for chronic arthritis |
15/08/2017 |
SSA |
|
Her1 vaccine in metastatic colon and prostate cancer |
16/08/2023 |
CIM |
|
HeberNasvac® Phase IV in Chronic Hepatitis B |
03/08/2018 |
CIGB |
|
HEBERFERON in renal cell carcinoma |
05/01/2017 |
CIGB |
|
HEBERBIOVAC HB vaccine to reference material. |
30/04/2017 |
CIGB |
|
Glizigen® and Oncoxin®-Viusid® in cervical intraepithelial lesions of adult women. Phase II |
09/05/2018 |
CATALYSIS |
|
Gastricel-I |
18/05/2018 |
CIDEM |
|
Feasibility and Effectiveness - MAP Online Program - Emerging Adults - Phase II |
30/01/2023 |
DIRECCION DE IN... |
|
Exploratory study to evaluate the effect and safety of CIGB 500 in seriously ill patients with shock |
06/07/2023 |
CIGB |
|
Expanded Clinical Use of Nasalferon in COVID-19 |
10/11/2021 |
CIGB |
|
Evaluation of the safety and immunogenicity of the vaccine candidate "ABDALA" in children and adolescents |
01/07/2021 |
CIGB |
|
Evaluation of the effectiveness of video games for attention intervention in school age boys and girls |
15/03/2023 |
CNEURO |
|
ESAR-814 Study |
26/01/2017 |
CIGB |
|
EPANEM-III |
2010-12-20 |
CIGB |
|
Enhanced recovery protocols in cardiac surgery protocols |
20/11/2019 |
HHA |
